AlphAIalphai — Financial news for AI agents
theglobeandmail.comAUG 201 min read$CC

Analysts Offer Insights on Materials Companies: Chemours Company (CC) and Solstice Advanced Materials, Inc. (SOLS)

Analysts Hassan Ahmed and John McNulty maintained Buy ratings on Chemours (CC) and Solstice Advanced Materials (SOLS), with price targets of $22.00 and $95.00 respectively. CC closed at $15.42, near its 52-week low, while SOLS closed at $60.09. Analyst consensus for CC is Moderate Buy ($19.78 avg. target), and for SOLS is Strong Buy ($80.17 avg. target).

Original reporting
theglobeandmail.com
Published Aug 20, 2026, 11:32 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 7:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Analysts Offer Insights on Materials Companies: Chemours Company (CC) and Solstice Advanced Materials, Inc. (SOLS) — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$CCBullishLow
01

Why it matters

Analyst upgrades may influence short‑term trading but lack a concrete catalyst.

02

Market read

Provides modest insight for traders tracking analyst sentiment in the materials sector.

03

What to watch

No new earnings or contract news; price targets rely on assumptions.

Relevance 4/10Novelty 2/10Timing: today

Background

The article aggregates recent analyst ratings for two materials companies, providing price targets and consensus views.

Company-level read

Ticker impact

$CCBullishMedium confidence
Context

Analyst Hassan Ahmed maintained a Buy rating on Chemours with a $22 price target, citing recent price near 52‑week low.

Expected impact

Small upside of ~10‑15% over weeks.

Evidence & confidence

Buy rating and target are new but no catalyst; price may drift toward target.

$SOLSBullishMedium confidence
Context

Analyst John McNulty maintained a Buy rating on Solstice Advanced Materials with a $95 price target, noting current price at $60.09.

Expected impact

Potential 30‑40% gain if target is reached.

Evidence & confidence

Buy rating and target are fresh but lack immediate catalyst; price may rise gradually.

Market effects

Sector

Analyst optimism may lift sentiment in the basic materials sector.

Regional

Limited to US markets where the stocks trade.

Global

Minimal global impact.

Counterpoint

What could challenge this read

Ratings could be overly optimistic given sector volatility.

Key entities

  • company
    Chemours Company

    Basic Materials firm, ticker CC.

  • company
    Solstice Advanced Materials, Inc.

    Basic Materials firm, ticker SOLS.

Read at source← All news

Related articles

AUG 8
$CCMed

Why Chemours Plunged on Wednesday

Chemours (NYSE: CC) shares fell 18.7% after its Q2 earnings. The company reported slight revenue decline and adjusted EPS of $0.42, down 31% year over year, meeting expectations. Management cited lower Optane refrigerant sales due to supply-chain inventory and the wind-down of the SPS Capstone business. Full-year growth guidance remains 1% to 5%.

aol.com6 min
AUG 5
$CCMed

Why Chemours Plunged on Wednesday

Chemours (NYSE: CC) shares fell 18.7% after the company reported Q2 results. Revenue edged down and adjusted EPS fell 31% to $0.42, missing expectations. Lower Optane refrigerant sales and the prior wind-down of the SPS Capstone business weighed on results. Chemours still forecasts full-year growth of 1% to 5%.

yahoo.com4 min
AUG 4
$CCMedAI 8/10

The Chemours Company Reports Second Quarter Results

Chemours (NYSE: CC) reported Q2 2026 results: net sales about $1.6B, roughly flat year over year. Net loss attributable to Chemours was $274M ($1.81 per diluted share) versus $380M ($2.53) a year earlier. Adjusted net income was $64M ($0.42) and adjusted EBITDA $247M. Free cash flow rose 128% and net leverage fell to 4.4x. Chemours cited TiO2 pricing actions and APM Performance Solutions growth.

prnewswire.com7 min
AUG 4
$CCMed

Chemours Co (CC): Results of Operations and Financial Condition

Chemours Co (CC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cc-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 The Chemours Company Reports Second Quarter Results Wilmington, Del., August 4, 2026 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Special

SEC EDGAR 8-K6 min
AUG 4
$SOLSMedAI 8/10

Solstice Advanced Materials (SOLS) Q2 2026 Earnings Call Transcript

Solstice Advanced Materials (SOLS) reported Q2 2026 net sales of $1.148B, up 11% YoY, and adjusted EBITDA of $290M, up 2% YoY, with margin at 25.3%. GAAP net income was $119M. Free cash flow for H1 2026 was $248M. The company raised full-year 2026 guidance and said it expects to close its Element Solutions acquisition in H1 2027.

yahoo.com6 min
JUL 31
$SOLSMedAI 8/10

Solstice Advanced Materials (SOLS) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026, at 8:30 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations - Michael Leithead President and Chief Executive Officer - David Sewell Chief Financial Officer - Tina Pierce TAKEAWAYS Net Sales -- $1.15 billion, representing 11% growth year over year and exceeding the top end of management's guidance range. Adjusted EBITDA -- $290 million, a 2% increase year over year, driven by volume growth and favorable pricing.

fool.com6 min